116 related articles for article (PubMed ID: 6193340)
1. Kinetic analysis of 5 alpha-reductase isoenzymes in benign prostatic hyperplasia (BPH).
Rennie PS; Bruchovsky N; McLoughlin MG; Batzold FH; Dunstan-Adams EE
J Steroid Biochem; 1983 Jul; 19(1A):169-73. PubMed ID: 6193340
[TBL] [Abstract][Full Text] [Related]
2. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
Boudon C; Lobaccaro JM; Lumbroso S; Lechevallier E; Mottet N; Gibelin B; Sultan C
Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1007-15. PubMed ID: 8747081
[TBL] [Abstract][Full Text] [Related]
3. Kinetic parameters of 5 alpha-reductase activity in stroma and epithelium of normal, hyperplastic, and carcinomatous human prostates.
Bruchovsky N; Rennie PS; Batzold FH; Goldenberg SL; Fletcher T; McLoughlin MG
J Clin Endocrinol Metab; 1988 Oct; 67(4):806-16. PubMed ID: 2458378
[TBL] [Abstract][Full Text] [Related]
4. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
Krieg M; Bartsch W; Thomsen M; Voigt KD
J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
[TBL] [Abstract][Full Text] [Related]
5. Effect of aging on kinetic parameters of 5 alpha-reductase in epithelium and stroma of normal and hyperplastic human prostate.
Tunn S; Hochstrate H; Grunwald I; Flüchter SH; Krieg M
J Clin Endocrinol Metab; 1988 Nov; 67(5):979-85. PubMed ID: 2460487
[TBL] [Abstract][Full Text] [Related]
6. [Activity of 5 alpha-reductase in human hyperplastic prostates].
Lin Y
Zhonghua Yi Xue Za Zhi; 1991 May; 71(5):263-5, 20. PubMed ID: 1713809
[TBL] [Abstract][Full Text] [Related]
7. Messenger RNA levels and enzyme activities of 5 alpha-reductase types 1 and 2 in human benign prostatic hyperplasia (BPH) tissue.
Shirakawa T; Okada H; Acharya B; Zhang Z; Hinata N; Wada Y; Uji T; Kamidono S; Gotoh A
Prostate; 2004 Jan; 58(1):33-40. PubMed ID: 14673950
[TBL] [Abstract][Full Text] [Related]
8. Effect of aging on kinetic parameters of 3 alpha(beta)-hydroxysteroid oxidoreductases in epithelium and stroma of human normal and hyperplastic prostate.
Tunn S; Haumann R; Hey J; Flüchter SH; Krieg M
J Clin Endocrinol Metab; 1990 Sep; 71(3):732-9. PubMed ID: 1697599
[TBL] [Abstract][Full Text] [Related]
9. [Androgen receptor and 5 alpha-reductase activity in the epithelium and the stroma of human benign prostatic hyperplasia].
Oishi K; Okada K; Yoshida O; Romijn JC; Bolt de Vries J; Schröder FH
Hinyokika Kiyo; 1985 May; 31(5):785-90. PubMed ID: 2413745
[TBL] [Abstract][Full Text] [Related]
10. 5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium.
Thomas LN; Douglas RC; Vessey JP; Gupta R; Fontaine D; Norman RW; Thompson IM; Troyer DA; Rittmaster RS; Lazier CB
J Urol; 2003 Nov; 170(5):2019-25. PubMed ID: 14532845
[TBL] [Abstract][Full Text] [Related]
11. Partial characterization of stromal and epithelial forms of 5 alpha-reductase in human prostate.
Bruchovsky N; McLoughlin MG; Rennie PS; To MP
Prog Clin Biol Res; 1981; 75A():161-75. PubMed ID: 6175974
[No Abstract] [Full Text] [Related]
12. Kinetic analysis of androstenedione 5 alpha-reductase in epithelium and stroma of human prostate.
Weisser H; Krieg M
Steroids; 1997; 62(8-9):589-94. PubMed ID: 9432753
[TBL] [Abstract][Full Text] [Related]
13. Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostate.
Span PN; Völler MC; Smals AG; Sweep FG; Schalken JA; Feneley MR; Kirby RS
J Urol; 1999 Jan; 161(1):332-7. PubMed ID: 10037433
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of androgen metabolism in stroma and epithelium of the human benign prostatic hyperplasia by progesterone, estrone, and estradiol.
Krieg M; Schlenker A; Voigt KD
Prostate; 1985; 6(3):233-40. PubMed ID: 2581234
[TBL] [Abstract][Full Text] [Related]
15. Oxytocin increases 5alpha-reductase activity of human prostate epithelial cells, but not stromal cells.
Assinder SJ
Prostate; 2008 Feb; 68(2):115-21. PubMed ID: 18008328
[TBL] [Abstract][Full Text] [Related]
16. Effects of the sabal serrulata extract IDS 89 and its subfractions on 5 alpha-reductase activity in human benign prostatic hyperplasia.
Weisser H; Tunn S; Behnke B; Krieg M
Prostate; 1996 May; 28(5):300-6. PubMed ID: 8610056
[TBL] [Abstract][Full Text] [Related]
17. Stromal 5 alpha-reductase activity is elevated in benign prostatic hyperplasia.
Wilkin RP; Bruchovsky N; Shnitka TK; Rennie PS; Comeau TL
Acta Endocrinol (Copenh); 1980 Jun; 94(2):284-8. PubMed ID: 6158242
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of 5 alpha-reductase gene expression in benign prostatic hyperplasia.
Sherwood JB; McConnell JD; Vazquez DJ; Lin VK; Roehrborn CG
J Urol; 2003 Feb; 169(2):575-9. PubMed ID: 12544310
[TBL] [Abstract][Full Text] [Related]
19. [Expression and significance of steroid 5alpha-reductase isoenzymes in benign hyperplastic prostate tissues].
Ye LF; Zhang YF; Fang ZJ; Ding Q; Yao MS
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1296-9. PubMed ID: 12930680
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of 5 alpha-reductase isoenzymes in the human prostate and prostatic carcinomas.
Bonkhoff H; Stein U; Aumüller G; Remberger K
Prostate; 1996 Oct; 29(4):261-7. PubMed ID: 8876709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]